Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
811.08
-12.15 (-1.48%)
Jan 31, 2025, 4:00 PM EST - Market closed

Eli Lilly Market Cap

Eli Lilly has a market cap or net worth of $730.32 billion as of January 31, 2025. Its market cap has increased by 22.33% in one year.

Market Cap
730.32B
Enterprise Value
757.48B
1-Year Change
22.33%
Ranking
Category
Stock Price
$811.08

Market Cap Chart

Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $730.32B, an increase of 635.86%. That is a compound annual growth rate of 7.92%.

History

DateMarket Cap% Change
Jan 31, 2025769.97B5.06%
Dec 31, 2024732.87B32.44%
Dec 29, 2023553.37B59.19%
Dec 30, 2022347.61B31.56%
Dec 31, 2021264.23B63.60%
Dec 31, 2020161.51B27.99%
Dec 31, 2019126.19B2.94%
Dec 31, 2018122.58B31.81%
Dec 29, 201793.00B14.54%
Dec 30, 201681.20B-13.04%
Dec 31, 201593.37B21.55%
Dec 31, 201476.82B33.69%
Dec 31, 201357.46B0.39%
Dec 31, 201257.23B18.95%
Dec 30, 201148.12B19.08%
Dec 31, 201040.41B-1.52%
Dec 31, 200941.03B-10.38%
Dec 31, 200845.79B-24.40%
Dec 31, 200760.56B2.72%
Dec 29, 200658.96B-8.34%
Dec 30, 200564.32B0.16%
Dec 31, 200464.22B-18.68%
Dec 31, 200378.97B10.71%
Dec 31, 200271.33B-19.21%
Dec 31, 200188.30B-15.83%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
UnitedHealth Group 500.34B
Novo Nordisk 376.62B
Johnson & Johnson 370.15B
AbbVie 310.84B
Merck & Co. 250.76B
Thermo Fisher Scientific 232.12B
Abbott Laboratories 223.77B
AstraZeneca 218.67B
Market Cap Rankings